Integrating tumor-immune mechanistic modeling with transcriptomics reveals pattern-driven prognostic biomarkers in tumors.
The spatial patterns of immune cells within the tumor microenvironment hold profound prognostic implications, yet a mechanistic understanding of their formation and functional impact remains lacking. Current mechanistic models operate in a theoretical vacuum, while spatial transcriptomics (ST) provides static snapshots...